Bavarian Nordic A/S/ DK0015998017 /

9/28/2023 4:59:36 PM	Chg. -0.65	Volume	Bid5:10:00 PM	Ask5:10:00 PM	High	Low
153.80DKK	-0.42%	181,827 Turnover: 23.08 mill.	153.85Bid Size: 188	154.10Ask Size: 37	155.35	153.20

TeleTrader 8/19/2022 EU makes monkeypox vaccine more available

TeleTrader 8/18/2022 WH announces new strategies against monkeypox

TeleTrader 7/30/2022 Spain confirms second monkeypox death

TeleTrader 7/29/2022 Spain confirms Europe's first monkeypox death

TeleTrader 7/25/2022 Monkeypox vaccine approved by EU

TeleTrader 7/22/2022 EMA gives preliminary approval to monkeypox jab

TeleTrader 6/14/2022 EU buys 110,000 monkeypox vaccines

TeleTrader 5/27/2022 EU to jointly buy antivirals, vaccines against monkeypox

GlobeNewswire 3/24/2022 Valneva Reports Full Year 2021 Results and Provides Corporate Updates

GlobeNewswire 3/21/2022 Bavarian Nordic Announces License and Supply Agreement with Nuance Pharma on the Development and Com...

GlobeNewswire 2/28/2022 Bavarian Nordic Reports Additional Positive Phase 2 Results for its COVID-19 Vaccine Candidate Ahead...

GlobeNewswire 2/14/2022 Bavarian Nordic Announces Breakthrough Therapy Designation for its RSV Vaccine Candidate for the Pre...

GlobeNewswire 2/3/2022 Valneva Reports Full Year 2021 Revenue and Cash; Provides First 2022 Guidance

GlobeNewswire 12/6/2021 Bavarian Nordic Commits to Initiating Phase 3 Trial of RSV Vaccine Candidate and to Strengthening it...

GlobeNewswire 12/5/2021 Bavarian Nordic Reports Positive Topline Phase 2 Results for its COVID-19 Vaccine Candidate

GlobeNewswire 11/18/2021 Valneva Reports Nine-Month 2021 Revenue and Cash

GlobeNewswire 9/1/2021 Bavarian Nordic Reports Positive Results from Human Challenge Trial of its RSV Vaccine Candidate

GlobeNewswire 8/23/2021 Bavarian Nordic Receives Funding from the Danish Ministry of Health to Advance the Development of CO...

GlobeNewswire 8/23/2021 Bavarian Nordic Initiates Phase 2 Clinical Trial of COVID-19 Booster Vaccine

GlobeNewswire 8/10/2021 Valneva Reports H1 2021 Financial Results and Provides Business Update

GlobeNewswire 8/9/2021 Bavarian Nordic Reports Initial Results from First-in-Human Trial of COVID-19 Vaccine

GlobeNewswire 6/11/2021 Bavarian Nordic Assists Public Health England in Response to New Cases of Monkeypox

GlobeNewswire 6/11/2021 Vor Biopharma Names Matthew R. Patterson as Chairman and Promotes Tania Philipp

GlobeNewswire 5/20/2021 Valneva Reports Q1 2021 Financial Results and Business Update

GlobeNewswire 4/19/2021 Arcellx Announces Executive Appointments